Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02249923 · ClinicalTrials.gov registry record
Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
A clinical trial of Pulmonary Arterial Hypertension and Pulmonary Vascular Disease, sponsored by New York Medical College.
- Recruiting
- Registry status
- 2,500
- Enrollment target
- 14
- Study locations
NCT02249923 is a study of Pulmonary Arterial Hypertension and Pulmonary Vascular Disease that is actively recruiting participants, run by New York Medical College. The registered enrollment target is 2,500 participants, above the 423-participant average among 63 other Pulmonary Arterial Hypertension trials with a reported enrollment target (491% higher). The trial reports 14 study locations across 12 states.
The verdict
NCT02249923, a study of Pulmonary Arterial Hypertension and Pulmonary Vascular Disease, is actively recruiting participants, sponsored by New York Medical College.
- RECRUITING
- Registry status
- 2,500 participants
- Enrollment target
- 14
- Study locations
Study Summary
Patients are being asked to be in this research study because medical researchers hope that by gathering information about a large number of children with pulmonary hypertension over time, their understanding of the disease process will increase and lead to better treatment. Investigators believe that pulmonary hypertension in children is different than pulmonary hypertension in adults and this study will help us understand those differences.
Conditions Studied
Study Locations (14)
California
- Stanford University Medical Center - Palo Alto
- University California San Francisco - San Francisco
New York
- Columbia University Medical Center - New York
- Maria Fareri Children's Hospital at WMC Health/Westchester Medical Center - New York
Colorado
- Children's Hospital Colorado - Aurora
Florida
- Johns Hopkins All Children's Heart Institute - St. Petersburg
Maryland
- Johns Hopkins Children's Center - Baltimore
Massachusetts
- Boston Children's Hospital - Boston
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,500 participants |
| Start Date | 2014-10 |
| Est. Completion | 2031-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02249923
The ClinicalTrials.gov registry entry for NCT02249923 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 423-participant average among 63 other Pulmonary Arterial Hypertension trials with a reported enrollment target (491% higher). The listed sponsor is New York Medical College, which has 47 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pulmonary Arterial Hypertension appearing as the primary indexed condition, and to 0 interventions.
NCT02249923 reports 14 study locations spanning 12 distinct geographic areas - top geographies include California, New York, Colorado.
Frequently Asked Questions
What is clinical trial NCT02249923 about?
NCT02249923 is a clinical study titled "Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry". Patients are being asked to be in this research study because medical researchers hope that by gathering information about a large number of children with pulmonary hypertension over time, their understanding of the disease process will increase and lead to better treatment. Investigators believe th...
What is the current status of trial NCT02249923?
This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2014-10. Estimated completion is 2031-12.
What conditions does trial NCT02249923 study?
This clinical trial studies the following conditions: Pulmonary Arterial Hypertension, Pulmonary Vascular Disease.
Who is sponsoring clinical trial NCT02249923?
This trial is sponsored by New York Medical College, which has 47 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02249923 being conducted?
This trial has 14 study locations across California, Colorado, Florida, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Arterial Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
RECRUITING · NA
-
The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study
RECRUITING · NA
-
Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH
RECRUITING · Phase 3
-
A Placebo-controlled, Randomized Clinical Trial to Assess the Safety, Feasibility, and Pharmacokinetics of Microbiota Transplant Therapy With Antibiotic Preconditioning and Fiber Supplementation in Patients With Pulmonary Arterial Hypertension
RECRUITING · Phase 1
-
129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)
RECRUITING · Phase 2
-
Pulmonary Hypertension SOLAR
RECRUITING · Phase 2
Explore more on PlainTrial
Pulmonary Arterial Hypertension
All registered trials for this condition
Pulmonary Vascular Disease
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.